Waltham, Mass. – March 10, 2020 – A new national survey shows a stark gap between the desire and ability to age in place in America, with nearly 2 in 3 adults saying they have a goal to age in place (65%), while only 1 in 3 think they realistically will (33%). The findings are one part of a larger survey examining aging in place commissioned by Fresenius Medical Care North America (FMCNA), the leading provider of products and services for people living with kidney failure.
Aging in place refers to the ability of an adult to live in their existing home or community regardless of age, income, or ability. The survey of 2,750 U.S. adults revealed three main factors that influence individuals’ ability to age in place: social determinants of (SDOH), presence and availability of one’s caregiver network, and the perceived quality of care.
“With adults living longer than ever before and a looming shortage in caregivers, it is critical for the healthcare community to commit to a future where older adults can age on their own terms,” said Bill Valle, Chief Executive Officer of FMCNA. “This is why our organization is leading efforts to provide more access to home therapies and connected health that will allow individuals to thrive in the settings where they feel most comfortable.”
As the U.S. government has pushed for expansion of home dialysis, telehealth, and other technologies aimed at treating chronic disease at home, FMCNA decided to further investigate specific attitudes toward aging in place. With demonstrated expertise in chronic healthcare and treating more than 200,000 people with kidney failure, FMCNA continuously interacts with patients and caregivers at various care touch points, creating a unique opportunity to better understand the realities and barriers one faces as they age.
“This research further demonstrates the importance of addressing social determinants of health to improve patients’ quality of life and the chances for aging in place successfully,” said Felicia Speed, Corporate Director of Social Work Services at Fresenius Kidney Care. “It also suggests we must continue to help educate patients about all the resources now available for people to receive care in their own home.”
The full survey results can be found here. Highlights of the results include:
Social Determinants of Health
Certain SDOH have an outsized impact on the general population’s ability to age in place. There is an immediate need to address SDOH so older adults can achieve their goal of aging in place.
Individuals living with CKD are highly motivated to age in place. In fact, 82% of CKD patients express a desire to do so compared to 65% of the general population.
A strong caregiver network is a key factor for adults being able to age in place. More than 1 in 3 U.S. adults say they are caring for a family member with a chronic health condition (34%) and nearly half of them are millennials under the age of 38 (41%).
Quality of Care at Home
Survey findings show that even patients with kidney failure on dialysis do not fully understand existing, beneficial home care options. Recent research confirms that home dialysis often leads to better outcomes while introducing greater independence and flexibility.
FMCNA is committed to closing the gap in the ability to age in place through education, technology, and efforts to address SDOH. These include:
For more information on the detailed survey findings and how FMCNA is beginning to address barriers to aging in place, please visit fmcna.com/aging-in-place/.
About Fresenius Medical Care North America
Fresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities, outpatient cardiac and vascular labs and urgent care centers, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com.
About the Survey
The data are findings from a survey conducted by Edelman Intelligence, an independent market research firm, on behalf of Fresenius Medical Care North America. A sample of 2,750 U.S. adults aged 18 years or older were interviewed online, in English during August 9-20, 2019. For more information, please visit fmcna.com/aging-in-place/.
About Edelman Intelligence
Edelman Intelligence is a global, full-service market insights and analytics firm that provides corporate, non-profit and government clients with strategic intelligence to make their communications and engagements with stakeholders the smartest they can be. The firm specializes in measurement, tracking and analysis in reputation, branding, and communications. Edelman Intelligence is part of Edelman, the world’s largest public relations company. Edelman Intelligence has more than 200 employees and 12 offices around the world.
For further information, please visit http://www.edelman.com/specialty/edelman-intelligence/
Fresenius Medical Care North America